CD47 and glioblastoma: In vitro analysis of mouse BMDM and peripheral blood-derived human macrophages have shown that the addition of anti-CD47 mAb enhances myeloid cell effector functions against glioblastoma cells regardless of the M1/M2 polarization status [26].